CLL in patients under 40

Selina M. Luger, MD
Ultima Vez Modificado: 6 de enero del 2002

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

Long-Term Remissions of CLL in First Personalized Cell Tx Trial

Sep 3, 2015

T cells reprogrammed to contain chimeric antigen receptor targeting CD19 protein on B cells

Anti-CD20 Antibody + Chemo Benefits CLL With Comorbidity

Jan 9, 2014

Findings show obinutuzumab superior to rituximab, when each combined with chlorambucil

Fludarabine, Alemtuzumab Combo Ups Survival in CLL

Oct 12, 2011

But combination therapy is associated with more adverse events than fludarabine monotherapy